Differential actions of VEGF-A isoforms on perichondrial angiogenesis during endochondral bone formation

Developmental Biology

Volumn 332, Issue 2, 2009, Pages 196-211

  Takimoto, Aki ^a   Nishizaki, Yuriko ^a   Hiraki, Yuji ^a   Shukunami, Chisa ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Anti angiogenic properties; Cartilage; Endochondral bone formation; Perichondrial angiogenesis; Perichondrium; VEGF A

Indexed keywords

COLLAGENASE 3; GELATINASE B; ISOPROTEIN; NEUROPILIN; RECOMBINANT VASCULOTROPIN; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; CONTROLLED STUDY; EMBRYO; ENCHONDRAL OSSIFICATION; FEMALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOCLAST; PERICHONDRIUM; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; SIGNAL TRANSDUCTION; TISSUE BLOOD FLOW;

MUS;

EID: 67650970081     PISSN: 00121606     EISSN: 1095564X     Source Type: Journal    
DOI: 10.1016/j.ydbio.2009.05.552     Document Type: Article

References (55)

1. Alvarez J., Sohn P., Zeng X., Doetschman T., Robbins D.J., and Serra R. TGFbeta2 mediates the effects of hedgehog on hypertrophic differentiation and PTHrP expression. Development 129 (2002) 1913-1924
2. Annes J.P., Munger J.S., and Rifkin D.B. Making sense of latent TGFbeta activation. J. Cell Sci. 116 (2003) 217-224
3. Bielenberg D.R., Hida Y., Shimizu A., Kaipainen A., Kreuter M., Kim C.C., and Klagsbrun M. Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype. J. Clin. Invest. 114 (2004) 1260-1271
4. Carmeliet P., and Jain R.K. Angiogenesis in cancer and other diseases. Nature 407 (2000) 249-257
5. Colnot C. Cellular and molecular interactions regulating skeletogenesis. J. Cell Biochem. 95 (2005) 688-697
6. Dallas S.L., Rosser J.L., Mundy G.R., and Bonewald L.F. Proteolysis of latent transforming growth factor-beta (TGF-beta)-binding protein-1 by osteoclasts. A cellular mechanism for release of TGF-beta from bone matrix. J. Biol. Chem. 277 (2002) 21352-21360
7. Engsig M.T., Chen Q.J., Vu T.H., Pedersen A.C., Therkidsen B., Lund L.R., Henriksen K., Lenhard T., Foged N.T., Werb Z., and Delaisse J.M. Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J. Cell Biol. 151 (2000) 879-889
8. Eshkar-Oren I., Viukov S.V., Salameh S., Krief S., Oh C.D., Akiyama H., Gerber H.P., Ferrara N., and Zelzer E. The forming limb skeleton serves as a signaling center for limb vasculature patterning via regulation of Vegf. Development 136 (2009) 1263-1272
9. Flamme I., von Reutern M., Drexler H.C., Syed-Ali S., and Risau W. Overexpression of vascular endothelial growth factor in the avian embryo induces hypervascularization and increased vascular permeability without alterations of embryonic pattern formation. Dev. Biol. 171 (1995) 399-414
10. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1 (1995) 27-31
11. Gerber H.P., Vu T.H., Ryan A.M., Kowalski J., Werb Z., and Ferrara N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat. Med. 5 (1999) 623-628
12. Gerhardt H., Golding M., Fruttiger M., Ruhrberg C., Lundkvist A., Abramsson A., Jeltsch M., Mitchell C., Alitalo K., Shima D., and Betsholtz C. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J. Cell Biol. 161 (2003) 1163-1177
13. Gerhardt H., Ruhrberg C., Abramsson A., Fujisawa H., Shima D., and Betsholtz C. Neuropilin-1 is required for endothelial tip cell guidance in the developing central nervous system. Dev. Dyn. 231 (2004) 503-509
14. Gerstenfeld L.C., Chipman S.D., Glowacki J., and Lian J.B. Expression of differentiated function by mineralizing cultures of chicken osteoblasts. Dev. Biol. 122 (1987) 49-60
15. Haigh J.J., Gerber H.P., Ferrara N., and Wagner E.F. Conditional inactivation of VEGF-A in areas of collagen2a1 expression results in embryonic lethality in the heterozygous state. Development 127 (2000) 1445-1453
16. Hallmann R., Feinberg R.N., Latker C.H., Sasse J., and Risau W. Regression of blood vessels precedes cartilage differentiation during chick limb development. Differentiation 34 (1987) 98-105
17. Hamburger V., and Hamilton H.L. A series of normal stages in the development of the chick embryo. 1951. Dev. Dyn. 195 (1992) 231-272
18. Hardingham T.E., and Fosang A.J. Proteoglycans: many forms and many functions. FASEB J. 6 (1992) 861-870
19. Herve M.A., Buteau-Lozano H., Vassy R., Bieche I., Velasco G., Pla M., Perret G., Mourah S., and Perrot-Applanat M. Overexpression of vascular endothelial growth factor 189 in breast cancer cells leads to delayed tumor uptake with dilated intratumoral vessels. Am. J. Pathol. 172 (2008) 167-178
20. Hiraki Y., Inoue H., Iyama K., Kamizono A., Ochiai M., Shukunami C., Iijima S., Suzuki F., and Kondo J. Identification of chondromodulin I as a novel endothelial cell growth inhibitor. Purification and its localization in the avascular zone of epiphyseal cartilage. J. Biol. Chem. 272 (1997) 32419-32426
21. Hogan B., Beddington R., Costantini F., and Lacy E. Manipulating the Mouse Embryo: A Laboratory Manual. 2nd ed. (1994), Cold Spring Harbor Laboratory Press, New York
22. Houck K.A., Leung D.W., Rowland A.M., Winer J., and Ferrara N. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J. Biol. Chem. 267 (1992) 26031-26037
23. Jakobsson L., Kreuger J., Holmborn K., Lundin L., Eriksson I., Kjellen L., and Claesson-Welsh L. Heparan sulfate in trans potentiates VEGFR-mediated angiogenesis. Dev. Cell 10 (2006) 625-634
24. Jia H., Bagherzadeh A., Hartzoulakis B., Jarvis A., Lohr M., Shaikh S., Aqil R., Cheng L., Tickner M., Esposito D., Harris R., Driscoll P.C., Selwood D.L., and Zachary I.C. Characterization of a bicyclic peptide neuropilin-1 (NP-1) antagonist (EG3287) reveals importance of vascular endothelial growth factor exon 8 for NP-1 binding and role of NP-1 in KDR signaling. J. Biol. Chem. 281 (2006) 13493-13502
25. Karsdal M.A., Hjorth P., Henriksen K., Kirkegaard T., Nielsen K.L., Lou H., Delaisse J.M., and Foged N.T. Transforming growth factor-beta controls human osteoclastogenesis through the p38 MAPK and regulation of RANK expression. J. Biol. Chem. 278 (2003) 44975-44987
26. Karsenty G., and Wagner E.F. Reaching a genetic and molecular understanding of skeletal development. Dev. Cell 2 (2002) 389-406
27. Kartsogiannis V., Zhou H., Horwood N.J., Thomas R.J., Hards D.K., Quinn J.M., Niforas P., Ng K.W., Martin T.J., and Gillespie M.T. Localization of RANKL (receptor activator of NF kappa B ligand) mRNA and protein in skeletal and extraskeletal tissues. Bone 25 (1999) 525-534
28. Koyama E., Leatherman J.L., Shimazu A., Nah H.D., and Pacifici M. Syndecan-3, tenascin-C, and the development of cartilaginous skeletal elements and joints in chick limbs. Dev. Dyn. 203 (1995) 152-162
29. Krilleke D., DeErkenez A., Schubert W., Giri I., Robinson G.S., Ng Y.S., and Shima D.T. Molecular mapping and functional characterization of the VEGF164 heparin-binding domain. J. Biol. Chem. 282 (2007) 28045-28056
30. Kuettner K.E., and Pauli B.U. Vascularity of cartilage. In: Hall B.K. (Ed). Cartilage 1 (1983), Academic Press, New York 281-312
31. Maes C., Carmeliet P., Moermans K., Stockmans I., Smets N., Collen D., Bouillon R., and Carmeliet G. Impaired angiogenesis and endochondral bone formation in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Mech. Dev. 111 (2002) 61-73
32. Maes C., Stockmans I., Moermans K., Van Looveren R., Smets N., Carmeliet P., Bouillon R., and Carmeliet G. Soluble VEGF isoforms are essential for establishing epiphyseal vascularization and regulating chondrocyte development and survival. J. Clin. Invest. 113 (2004) 188-199
33. Nakashima K., Zhou X., Kunkel G., Zhang Z., Deng J.M., Behringer R.R., and de Crombrugghe B. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108 (2002) 17-29
34. Ogura T. In vivo electroporation: a new frontier for gene delivery and embryology. Differentiation 70 (2002) 163-171
35. Oh H., Takagi H., Otani A., Koyama S., Kemmochi S., Uemura A., and Honda Y. Selective induction of neuropilin-1 by vascular endothelial growth factor (VEGF): a mechanism contributing to VEGF-induced angiogenesis. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 383-388
36. Olsson A.K., Dimberg A., Kreuger J., and Claesson-Welsh L. VEGF receptor signalling - in control of vascular function. Nat. Rev. Mol. Cell Biol. 7 (2006) 359-371
37. Ortega N., Behonick D., Stickens D., and Werb Z. How proteases regulate bone morphogenesis. Ann. N. Y. Acad. Sci. 995 (2003) 109-116
38. Saadeh P.B., Mehrara B.J., Steinbrech D.S., Dudziak M.E., Greenwald J.A., Luchs J.S., Spector J.A., Ueno H., Gittes G.K., and Longaker M.T. Transforming growth factor-beta1 modulates the expression of vascular endothelial growth factor by osteoblasts. Am. J. Physiol. 277 (1999) C628-C637
39. Sasaki H., Hui C., Nakafuku M., and Kondoh H. A binding site for Gli proteins is essential for HNF-3beta floor plate enhancer activity in transgenics and can respond to Shh in vitro. Development 124 (1997) 1313-1322
40. Shibuya M., and Claesson-Welsh L. Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Exp. Cell Res. 312 (2006) 549-560
41. Shukunami C., Takimoto A., Oro M., and Hiraki Y. Scleraxis positively regulates the expression of tenomodulin, a differentiation marker of tenocytes. Dev. Biol. 298 (2006) 234-247
42. Shukunami C., Takimoto A., Miura S., Nishizaki Y., and Hiraki Y. Chondromodulin-I and tenomodulin are differentially expressed in the avascular mesenchyme during mouse and chick development. Cell Tissue Res. 332 (2008) 111-122
43. Soker S., Takashima S., Miao H.Q., Neufeld G., and Klagsbrun M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92 (1998) 735-745
44. Staton C., Kumar I., Reed M., and Brown N. Neuropilins in physiological and pathological angiogenesis. J. Pathol. 212 (2007) 237-248
45. Stickens D., Behonick D.J., Ortega N., Heyer B., Hartenstein B., Yu Y., Fosang A.J., Schorpp-Kistner M., Angel P., and Werb Z. Altered endochondral bone development in matrix metalloproteinase 13-deficient mice. Development 131 (2004) 5883-5895
46. St-Jacques B., Hammerschmidt M., and McMahon A.P. Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation. Genes Dev. 13 (1999) 2072-2086
47. Takeda S., Bonnamy J.P., Owen M.J., Ducy P., and Karsenty G. Continuous expression of Cbfa1 in nonhypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocyte differentiation and partially rescues Cbfa1-deficient mice. Genes Dev. 15 (2001) 467-481
48. Tsumaki N., Kimura T., Matsui Y., Nakata K., and Ochi T. Separable cis-regulatory elements that contribute to tissue- and site-specific alpha 2(XI) collagen gene expression in the embryonic mouse cartilage. J. Cell Biol. 134 (1996) 1573-1582
49. Tsumaki N., Nakase T., Miyaji T., Kakiuchi M., Kimura T., Ochi T., and Yoshikawa H. Bone morphogenetic protein signals are required for cartilage formation and differently regulate joint development during skeletogenesis. J. Bone Miner. Res. 17 (2002) 898-906
50. von Wronski M.A., Tweedle M.F., and Nunn A.D. Binding of the C-terminal amino acids of VEGF121 directly with neuropilin-1 should be considered. FASEB J. 21 (2007) 1292 author reply 1293
51. Vortkamp A., Lee K., Lanske B., Segre G.V., Kronenberg H.M., and Tabin C.J. Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein. Science 273 (1996) 613-622
52. Vu T.H., Shipley J.M., Bergers G., Berger J.E., Helms J.A., Hanahan D., Shapiro S.D., Senior R.M., and Werb Z. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93 (1998) 411-422
53. Yu Q., and Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev. 14 (2000) 163-176
54. Zelzer E., Glotzer D.J., Hartmann C., Thomas D., Fukai N., Soker S., and Olsen B.R. Tissue specific regulation of VEGF expression during bone development requires Cbfa1/Runx2. Mech. Dev. 106 (2001) 97-106
55. Zelzer E., McLean W., Ng Y.S., Fukai N., Reginato A.M., Lovejoy S., D'Amore P.A., and Olsen B.R. Skeletal defects in VEGF(120/120) mice reveal multiple roles for VEGF in skeletogenesis. Development 129 (2002) 1893-1904